nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—oviduct—ovarian cancer	0.0487	0.157	CbGeAlD
Acetazolamide—AQP1—myometrium—ovarian cancer	0.0156	0.0503	CbGeAlD
Acetazolamide—AQP1—epithelium—ovarian cancer	0.0122	0.0395	CbGeAlD
Acetazolamide—AQP1—uterine cervix—ovarian cancer	0.0121	0.0392	CbGeAlD
Acetazolamide—AQP1—decidua—ovarian cancer	0.0116	0.0373	CbGeAlD
Acetazolamide—CA3—myometrium—ovarian cancer	0.0114	0.0369	CbGeAlD
Acetazolamide—AQP1—endometrium—ovarian cancer	0.011	0.0354	CbGeAlD
Acetazolamide—CA5A—female reproductive system—ovarian cancer	0.0109	0.0353	CbGeAlD
Acetazolamide—AQP1—uterus—ovarian cancer	0.0101	0.0327	CbGeAlD
Acetazolamide—AQP1—female reproductive system—ovarian cancer	0.00909	0.0294	CbGeAlD
Acetazolamide—CA3—uterine cervix—ovarian cancer	0.0089	0.0287	CbGeAlD
Acetazolamide—AQP1—bone marrow—ovarian cancer	0.00858	0.0277	CbGeAlD
Acetazolamide—AQP1—female gonad—ovarian cancer	0.00827	0.0267	CbGeAlD
Acetazolamide—AQP1—vagina—ovarian cancer	0.00822	0.0266	CbGeAlD
Acetazolamide—CA3—uterus—ovarian cancer	0.00742	0.0239	CbGeAlD
Acetazolamide—AQP1—testis—ovarian cancer	0.00734	0.0237	CbGeAlD
Acetazolamide—CA9—female reproductive system—ovarian cancer	0.00638	0.0206	CbGeAlD
Acetazolamide—CA3—bone marrow—ovarian cancer	0.00629	0.0203	CbGeAlD
Acetazolamide—CA3—vagina—ovarian cancer	0.00603	0.0195	CbGeAlD
Acetazolamide—CA3—testis—ovarian cancer	0.00538	0.0174	CbGeAlD
Acetazolamide—AQP1—lymph node—ovarian cancer	0.00532	0.0172	CbGeAlD
Acetazolamide—CA9—testis—ovarian cancer	0.00515	0.0166	CbGeAlD
Acetazolamide—CA5B—gonad—ovarian cancer	0.00474	0.0153	CbGeAlD
Acetazolamide—CA12—female reproductive system—ovarian cancer	0.00472	0.0152	CbGeAlD
Acetazolamide—CA5B—female reproductive system—ovarian cancer	0.00423	0.0137	CbGeAlD
Acetazolamide—CA2—embryo—ovarian cancer	0.004	0.0129	CbGeAlD
Acetazolamide—CA3—lymph node—ovarian cancer	0.0039	0.0126	CbGeAlD
Acetazolamide—CA5B—vagina—ovarian cancer	0.00383	0.0124	CbGeAlD
Acetazolamide—CA1—female reproductive system—ovarian cancer	0.00374	0.0121	CbGeAlD
Acetazolamide—CA1—bone marrow—ovarian cancer	0.00353	0.0114	CbGeAlD
Acetazolamide—CA5B—testis—ovarian cancer	0.00342	0.011	CbGeAlD
Acetazolamide—CA2—epithelium—ovarian cancer	0.00326	0.0105	CbGeAlD
Acetazolamide—CA2—decidua—ovarian cancer	0.00308	0.00995	CbGeAlD
Acetazolamide—CA4—female reproductive system—ovarian cancer	0.00292	0.00944	CbGeAlD
Acetazolamide—CA4—bone marrow—ovarian cancer	0.00276	0.00891	CbGeAlD
Acetazolamide—CA4—female gonad—ovarian cancer	0.00266	0.00859	CbGeAlD
Acetazolamide—Urine output increased—Paclitaxel—ovarian cancer	0.00265	0.00491	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Melphalan—ovarian cancer	0.00264	0.00489	CcSEcCtD
Acetazolamide—Hypoaesthesia—Topotecan—ovarian cancer	0.00254	0.00471	CcSEcCtD
Acetazolamide—CA5B—lymph node—ovarian cancer	0.00248	0.008	CbGeAlD
Acetazolamide—CA2—female reproductive system—ovarian cancer	0.00242	0.00783	CbGeAlD
Acetazolamide—Polyuria—Paclitaxel—ovarian cancer	0.00242	0.00449	CcSEcCtD
Acetazolamide—CA4—testis—ovarian cancer	0.00236	0.00762	CbGeAlD
Acetazolamide—Flushing—Melphalan—ovarian cancer	0.00232	0.00431	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.0023	0.00427	CcSEcCtD
Acetazolamide—Agitation—Chlorambucil—ovarian cancer	0.0023	0.00426	CcSEcCtD
Acetazolamide—CA2—bone marrow—ovarian cancer	0.00229	0.00739	CbGeAlD
Acetazolamide—Agranulocytosis—Vinorelbine—ovarian cancer	0.00227	0.00421	CcSEcCtD
Acetazolamide—Leukopenia—Chlorambucil—ovarian cancer	0.00224	0.00415	CcSEcCtD
Acetazolamide—CA2—female gonad—ovarian cancer	0.00221	0.00712	CbGeAlD
Acetazolamide—CA2—vagina—ovarian cancer	0.00219	0.00708	CbGeAlD
Acetazolamide—CA1—lymph node—ovarian cancer	0.00219	0.00707	CbGeAlD
Acetazolamide—Hypoglycaemia—Paclitaxel—ovarian cancer	0.00218	0.00404	CcSEcCtD
Acetazolamide—Hypoaesthesia—Vinorelbine—ovarian cancer	0.00218	0.00403	CcSEcCtD
Acetazolamide—Convulsion—Chlorambucil—ovarian cancer	0.00217	0.00401	CcSEcCtD
Acetazolamide—Hyponatraemia—Paclitaxel—ovarian cancer	0.00214	0.00396	CcSEcCtD
Acetazolamide—Glycosuria—Epirubicin—ovarian cancer	0.00207	0.00383	CcSEcCtD
Acetazolamide—Ill-defined disorder—Topotecan—ovarian cancer	0.00207	0.00383	CcSEcCtD
Acetazolamide—Confusional state—Chlorambucil—ovarian cancer	0.00206	0.00381	CcSEcCtD
Acetazolamide—Injection site pain—Epirubicin—ovarian cancer	0.00205	0.0038	CcSEcCtD
Acetazolamide—Flushing—Vinorelbine—ovarian cancer	0.00203	0.00376	CcSEcCtD
Acetazolamide—Malaise—Topotecan—ovarian cancer	0.00201	0.00372	CcSEcCtD
Acetazolamide—Hepatic failure—Docetaxel—ovarian cancer	0.00201	0.00372	CcSEcCtD
Acetazolamide—Blood disorder—Epirubicin—ovarian cancer	0.00201	0.00372	CcSEcCtD
Acetazolamide—Ataxia—Paclitaxel—ovarian cancer	0.002	0.00371	CcSEcCtD
Acetazolamide—Thrombocytopenia—Chlorambucil—ovarian cancer	0.002	0.0037	CcSEcCtD
Acetazolamide—Leukopenia—Topotecan—ovarian cancer	0.00199	0.00369	CcSEcCtD
Acetazolamide—CA2—testis—ovarian cancer	0.00196	0.00632	CbGeAlD
Acetazolamide—Leukopenia—Melphalan—ovarian cancer	0.00195	0.00361	CcSEcCtD
Acetazolamide—Hypokalaemia—Paclitaxel—ovarian cancer	0.00194	0.00359	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.00192	0.00355	CcSEcCtD
Acetazolamide—Glycosuria—Doxorubicin—ovarian cancer	0.00191	0.00354	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Epirubicin—ovarian cancer	0.00191	0.00353	CcSEcCtD
Acetazolamide—Injection site pain—Doxorubicin—ovarian cancer	0.0019	0.00352	CcSEcCtD
Acetazolamide—Convulsion—Melphalan—ovarian cancer	0.00189	0.0035	CcSEcCtD
Acetazolamide—Discomfort—Topotecan—ovarian cancer	0.00187	0.00347	CcSEcCtD
Acetazolamide—Blood disorder—Doxorubicin—ovarian cancer	0.00186	0.00344	CcSEcCtD
Acetazolamide—Anaphylactic shock—Topotecan—ovarian cancer	0.00182	0.00337	CcSEcCtD
Acetazolamide—Hyponatraemia—Docetaxel—ovarian cancer	0.00181	0.00335	CcSEcCtD
Acetazolamide—Dyspepsia—Chlorambucil—ovarian cancer	0.0018	0.00333	CcSEcCtD
Acetazolamide—Anaphylactic shock—Melphalan—ovarian cancer	0.00178	0.0033	CcSEcCtD
Acetazolamide—Thrombocytopenia—Topotecan—ovarian cancer	0.00178	0.0033	CcSEcCtD
Acetazolamide—Decreased appetite—Chlorambucil—ovarian cancer	0.00177	0.00329	CcSEcCtD
Acetazolamide—Ill-defined disorder—Vinorelbine—ovarian cancer	0.00177	0.00327	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Doxorubicin—ovarian cancer	0.00176	0.00327	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.00176	0.00326	CcSEcCtD
Acetazolamide—Fatigue—Chlorambucil—ovarian cancer	0.00176	0.00326	CcSEcCtD
Acetazolamide—Thrombocytopenia—Melphalan—ovarian cancer	0.00174	0.00323	CcSEcCtD
Acetazolamide—Malaise—Vinorelbine—ovarian cancer	0.00172	0.00318	CcSEcCtD
Acetazolamide—CA4—lymph node—ovarian cancer	0.00171	0.00552	CbGeAlD
Acetazolamide—Leukopenia—Vinorelbine—ovarian cancer	0.0017	0.00316	CcSEcCtD
Acetazolamide—Ataxia—Docetaxel—ovarian cancer	0.0017	0.00314	CcSEcCtD
Acetazolamide—Feeling abnormal—Chlorambucil—ovarian cancer	0.00168	0.00312	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00168	0.00311	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—ovarian cancer	0.00164	0.00303	CcSEcCtD
Acetazolamide—Paraesthesia—Topotecan—ovarian cancer	0.00163	0.00302	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00162	0.00301	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00162	0.00301	CcSEcCtD
Acetazolamide—Urticaria—Chlorambucil—ovarian cancer	0.00162	0.003	CcSEcCtD
Acetazolamide—Body temperature increased—Chlorambucil—ovarian cancer	0.00161	0.00299	CcSEcCtD
Acetazolamide—Discomfort—Vinorelbine—ovarian cancer	0.0016	0.00297	CcSEcCtD
Acetazolamide—Dyspepsia—Topotecan—ovarian cancer	0.0016	0.00296	CcSEcCtD
Acetazolamide—Paraesthesia—Melphalan—ovarian cancer	0.0016	0.00296	CcSEcCtD
Acetazolamide—Decreased appetite—Topotecan—ovarian cancer	0.00158	0.00293	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—ovarian cancer	0.00157	0.00291	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Topotecan—ovarian cancer	0.00157	0.00291	CcSEcCtD
Acetazolamide—Fatigue—Topotecan—ovarian cancer	0.00157	0.0029	CcSEcCtD
Acetazolamide—Dyspepsia—Melphalan—ovarian cancer	0.00157	0.0029	CcSEcCtD
Acetazolamide—CYP3A4—female reproductive system—ovarian cancer	0.00156	0.00505	CbGeAlD
Acetazolamide—Haematuria—Paclitaxel—ovarian cancer	0.00156	0.0029	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00155	0.00288	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.00155	0.00287	CcSEcCtD
Acetazolamide—Decreased appetite—Melphalan—ovarian cancer	0.00155	0.00287	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Melphalan—ovarian cancer	0.00154	0.00285	CcSEcCtD
Acetazolamide—Fatigue—Melphalan—ovarian cancer	0.00153	0.00284	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00152	0.00282	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—ovarian cancer	0.00151	0.0028	CcSEcCtD
Acetazolamide—Feeling abnormal—Topotecan—ovarian cancer	0.0015	0.00277	CcSEcCtD
Acetazolamide—Asthenia—Chlorambucil—ovarian cancer	0.00146	0.00271	CcSEcCtD
Acetazolamide—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00146	0.00271	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—ovarian cancer	0.00146	0.0027	CcSEcCtD
Acetazolamide—Urticaria—Topotecan—ovarian cancer	0.00144	0.00267	CcSEcCtD
Acetazolamide—Body temperature increased—Topotecan—ovarian cancer	0.00144	0.00266	CcSEcCtD
Acetazolamide—CA2—lymph node—ovarian cancer	0.00142	0.00458	CbGeAlD
Acetazolamide—Urticaria—Melphalan—ovarian cancer	0.00141	0.00262	CcSEcCtD
Acetazolamide—Diarrhoea—Chlorambucil—ovarian cancer	0.0014	0.00259	CcSEcCtD
Acetazolamide—Paraesthesia—Vinorelbine—ovarian cancer	0.0014	0.00259	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—ovarian cancer	0.00139	0.00258	CcSEcCtD
Acetazolamide—Erythema multiforme—Paclitaxel—ovarian cancer	0.00139	0.00258	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—ovarian cancer	0.00138	0.00257	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00138	0.00255	CcSEcCtD
Acetazolamide—Tinnitus—Paclitaxel—ovarian cancer	0.00137	0.00254	CcSEcCtD
Acetazolamide—Flushing—Paclitaxel—ovarian cancer	0.00137	0.00253	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—ovarian cancer	0.00135	0.00251	CcSEcCtD
Acetazolamide—Decreased appetite—Vinorelbine—ovarian cancer	0.00135	0.0025	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.00134	0.00249	CcSEcCtD
Acetazolamide—Fatigue—Vinorelbine—ovarian cancer	0.00134	0.00248	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Docetaxel—ovarian cancer	0.00131	0.00243	CcSEcCtD
Acetazolamide—Asthenia—Topotecan—ovarian cancer	0.0013	0.00241	CcSEcCtD
Acetazolamide—Vomiting—Chlorambucil—ovarian cancer	0.0013	0.0024	CcSEcCtD
Acetazolamide—Agranulocytosis—Docetaxel—ovarian cancer	0.0013	0.0024	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.00129	0.00239	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—ovarian cancer	0.00128	0.00237	CcSEcCtD
Acetazolamide—Feeling abnormal—Vinorelbine—ovarian cancer	0.00128	0.00237	CcSEcCtD
Acetazolamide—Asthenia—Melphalan—ovarian cancer	0.00128	0.00236	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00126	0.00233	CcSEcCtD
Acetazolamide—Dysgeusia—Paclitaxel—ovarian cancer	0.00125	0.00232	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—ovarian cancer	0.00125	0.00232	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—ovarian cancer	0.00125	0.00231	CcSEcCtD
Acetazolamide—Diarrhoea—Topotecan—ovarian cancer	0.00124	0.0023	CcSEcCtD
Acetazolamide—Hypoaesthesia—Docetaxel—ovarian cancer	0.00124	0.0023	CcSEcCtD
Acetazolamide—Urticaria—Vinorelbine—ovarian cancer	0.00123	0.00229	CcSEcCtD
Acetazolamide—Body temperature increased—Vinorelbine—ovarian cancer	0.00123	0.00228	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—ovarian cancer	0.00122	0.00226	CcSEcCtD
Acetazolamide—Diarrhoea—Melphalan—ovarian cancer	0.00122	0.00226	CcSEcCtD
Acetazolamide—Nausea—Chlorambucil—ovarian cancer	0.00121	0.00225	CcSEcCtD
Acetazolamide—Dizziness—Topotecan—ovarian cancer	0.0012	0.00223	CcSEcCtD
Acetazolamide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00119	0.0022	CcSEcCtD
Acetazolamide—Erythema multiforme—Docetaxel—ovarian cancer	0.00118	0.00218	CcSEcCtD
Acetazolamide—Agitation—Paclitaxel—ovarian cancer	0.00118	0.00218	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00116	0.00215	CcSEcCtD
Acetazolamide—Flushing—Docetaxel—ovarian cancer	0.00116	0.00214	CcSEcCtD
Acetazolamide—Vomiting—Topotecan—ovarian cancer	0.00116	0.00214	CcSEcCtD
Acetazolamide—Malaise—Paclitaxel—ovarian cancer	0.00116	0.00214	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—ovarian cancer	0.00115	0.00214	CcSEcCtD
Acetazolamide—Leukopenia—Paclitaxel—ovarian cancer	0.00115	0.00212	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—ovarian cancer	0.00114	0.00212	CcSEcCtD
Acetazolamide—Headache—Topotecan—ovarian cancer	0.00114	0.00211	CcSEcCtD
Acetazolamide—Vomiting—Melphalan—ovarian cancer	0.00113	0.0021	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—ovarian cancer	0.00113	0.00209	CcSEcCtD
Acetazolamide—Asthenia—Vinorelbine—ovarian cancer	0.00112	0.00207	CcSEcCtD
Acetazolamide—Convulsion—Paclitaxel—ovarian cancer	0.00111	0.00206	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—ovarian cancer	0.00111	0.00205	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00109	0.00203	CcSEcCtD
Acetazolamide—Nausea—Topotecan—ovarian cancer	0.00108	0.002	CcSEcCtD
Acetazolamide—Discomfort—Paclitaxel—ovarian cancer	0.00108	0.002	CcSEcCtD
Acetazolamide—Diarrhoea—Vinorelbine—ovarian cancer	0.00106	0.00197	CcSEcCtD
Acetazolamide—Dysgeusia—Docetaxel—ovarian cancer	0.00106	0.00197	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—ovarian cancer	0.00106	0.00196	CcSEcCtD
Acetazolamide—Nausea—Melphalan—ovarian cancer	0.00106	0.00196	CcSEcCtD
Acetazolamide—Confusional state—Paclitaxel—ovarian cancer	0.00105	0.00195	CcSEcCtD
Acetazolamide—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00105	0.00194	CcSEcCtD
Acetazolamide—Shock—Paclitaxel—ovarian cancer	0.00103	0.00191	CcSEcCtD
Acetazolamide—Dizziness—Vinorelbine—ovarian cancer	0.00103	0.0019	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—ovarian cancer	0.00102	0.0019	CcSEcCtD
Acetazolamide—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00102	0.0019	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00101	0.00188	CcSEcCtD
Acetazolamide—Vomiting—Vinorelbine—ovarian cancer	0.000988	0.00183	CcSEcCtD
Acetazolamide—Headache—Vinorelbine—ovarian cancer	0.000974	0.0018	CcSEcCtD
Acetazolamide—Leukopenia—Docetaxel—ovarian cancer	0.000972	0.0018	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000959	0.00178	CcSEcCtD
Acetazolamide—Convulsion—Docetaxel—ovarian cancer	0.000941	0.00174	CcSEcCtD
Acetazolamide—Paraesthesia—Paclitaxel—ovarian cancer	0.000939	0.00174	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—ovarian cancer	0.000937	0.00174	CcSEcCtD
Acetazolamide—Somnolence—Paclitaxel—ovarian cancer	0.000929	0.00172	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000929	0.00172	CcSEcCtD
Acetazolamide—Nausea—Vinorelbine—ovarian cancer	0.000923	0.00171	CcSEcCtD
Acetazolamide—Dyspepsia—Paclitaxel—ovarian cancer	0.00092	0.0017	CcSEcCtD
Acetazolamide—Decreased appetite—Paclitaxel—ovarian cancer	0.000909	0.00168	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000902	0.00167	CcSEcCtD
Acetazolamide—Fatigue—Paclitaxel—ovarian cancer	0.000901	0.00167	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—ovarian cancer	0.000893	0.00166	CcSEcCtD
Acetazolamide—Confusional state—Docetaxel—ovarian cancer	0.000893	0.00166	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000888	0.00164	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000886	0.00164	CcSEcCtD
Acetazolamide—Anaphylactic shock—Docetaxel—ovarian cancer	0.000886	0.00164	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—ovarian cancer	0.000874	0.00162	CcSEcCtD
Acetazolamide—Shock—Docetaxel—ovarian cancer	0.000872	0.00162	CcSEcCtD
Acetazolamide—Thrombocytopenia—Docetaxel—ovarian cancer	0.000868	0.00161	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—ovarian cancer	0.000867	0.00161	CcSEcCtD
Acetazolamide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000861	0.0016	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00086	0.00159	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—ovarian cancer	0.000837	0.00155	CcSEcCtD
Acetazolamide—Urticaria—Paclitaxel—ovarian cancer	0.00083	0.00154	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—ovarian cancer	0.000827	0.00153	CcSEcCtD
Acetazolamide—Body temperature increased—Paclitaxel—ovarian cancer	0.000826	0.00153	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00082	0.00152	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—ovarian cancer	0.000809	0.0015	CcSEcCtD
Acetazolamide—Paraesthesia—Docetaxel—ovarian cancer	0.000796	0.00147	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—ovarian cancer	0.000795	0.00147	CcSEcCtD
Acetazolamide—Somnolence—Docetaxel—ovarian cancer	0.000788	0.00146	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—ovarian cancer	0.000784	0.00145	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—ovarian cancer	0.000781	0.00145	CcSEcCtD
Acetazolamide—Dyspepsia—Docetaxel—ovarian cancer	0.00078	0.00145	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000774	0.00143	CcSEcCtD
Acetazolamide—Decreased appetite—Docetaxel—ovarian cancer	0.00077	0.00143	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000765	0.00142	CcSEcCtD
Acetazolamide—Fatigue—Docetaxel—ovarian cancer	0.000764	0.00142	CcSEcCtD
Acetazolamide—Asthenia—Paclitaxel—ovarian cancer	0.00075	0.00139	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—ovarian cancer	0.000736	0.00136	CcSEcCtD
Acetazolamide—Feeling abnormal—Docetaxel—ovarian cancer	0.00073	0.00135	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—ovarian cancer	0.000726	0.00134	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—ovarian cancer	0.000722	0.00134	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—ovarian cancer	0.000717	0.00133	CcSEcCtD
Acetazolamide—Diarrhoea—Paclitaxel—ovarian cancer	0.000715	0.00133	CcSEcCtD
Acetazolamide—Body temperature increased—Docetaxel—ovarian cancer	0.0007	0.0013	CcSEcCtD
Acetazolamide—Dizziness—Paclitaxel—ovarian cancer	0.000691	0.00128	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000679	0.00126	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—ovarian cancer	0.000673	0.00125	CcSEcCtD
Acetazolamide—Vomiting—Paclitaxel—ovarian cancer	0.000665	0.00123	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—ovarian cancer	0.000664	0.00123	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—ovarian cancer	0.00066	0.00122	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—ovarian cancer	0.000655	0.00121	CcSEcCtD
Acetazolamide—Headache—Paclitaxel—ovarian cancer	0.000655	0.00121	CcSEcCtD
Acetazolamide—Asthenia—Docetaxel—ovarian cancer	0.000636	0.00118	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—ovarian cancer	0.000634	0.00118	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000629	0.00116	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—ovarian cancer	0.000623	0.00115	CcSEcCtD
Acetazolamide—Nausea—Paclitaxel—ovarian cancer	0.000621	0.00115	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—ovarian cancer	0.000616	0.00114	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—ovarian cancer	0.000611	0.00113	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—ovarian cancer	0.000606	0.00112	CcSEcCtD
Acetazolamide—Diarrhoea—Docetaxel—ovarian cancer	0.000606	0.00112	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—ovarian cancer	0.000603	0.00112	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—ovarian cancer	0.000598	0.00111	CcSEcCtD
Acetazolamide—Shock—Epirubicin—ovarian cancer	0.000588	0.00109	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—ovarian cancer	0.000587	0.00109	CcSEcCtD
Acetazolamide—Dizziness—Docetaxel—ovarian cancer	0.000586	0.00109	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—ovarian cancer	0.000585	0.00108	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—ovarian cancer	0.00057	0.00106	CcSEcCtD
Acetazolamide—Vomiting—Docetaxel—ovarian cancer	0.000563	0.00104	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—ovarian cancer	0.000558	0.00103	CcSEcCtD
Acetazolamide—Headache—Docetaxel—ovarian cancer	0.000555	0.00103	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000553	0.00102	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—ovarian cancer	0.000544	0.00101	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000541	0.001	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—ovarian cancer	0.000537	0.000994	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—ovarian cancer	0.000531	0.000984	CcSEcCtD
Acetazolamide—Nausea—Docetaxel—ovarian cancer	0.000526	0.000975	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—ovarian cancer	0.000526	0.000975	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—ovarian cancer	0.00052	0.000963	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000516	0.000956	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—ovarian cancer	0.000515	0.000955	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—ovarian cancer	0.000497	0.00092	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—ovarian cancer	0.000492	0.000912	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—ovarian cancer	0.000492	0.000911	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—ovarian cancer	0.000487	0.000902	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—ovarian cancer	0.000481	0.000891	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000477	0.000884	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—ovarian cancer	0.000477	0.000883	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—ovarian cancer	0.000475	0.00088	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—ovarian cancer	0.000472	0.000875	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000456	0.000844	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—ovarian cancer	0.000439	0.000814	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—ovarian cancer	0.000437	0.00081	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—ovarian cancer	0.000429	0.000794	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—ovarian cancer	0.000409	0.000758	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—ovarian cancer	0.000397	0.000735	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—ovarian cancer	0.000395	0.000732	CcSEcCtD
Acetazolamide—Vomiting—Epirubicin—ovarian cancer	0.00038	0.000704	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—ovarian cancer	0.000378	0.000701	CcSEcCtD
Acetazolamide—Headache—Epirubicin—ovarian cancer	0.000374	0.000694	CcSEcCtD
Acetazolamide—CA6—Metabolism—PPP1CC—ovarian cancer	0.000372	0.00247	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPP1CC—ovarian cancer	0.000372	0.00247	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—BRIP1—ovarian cancer	0.000372	0.00247	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—BRIP1—ovarian cancer	0.000372	0.00247	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NME2—ovarian cancer	0.000368	0.00245	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYTB—ovarian cancer	0.000368	0.00245	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—KRAS—ovarian cancer	0.000368	0.00244	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—SLC5A5—ovarian cancer	0.000368	0.00244	CbGpPWpGaD
Acetazolamide—Dizziness—Doxorubicin—ovarian cancer	0.000366	0.000677	CcSEcCtD
Acetazolamide—AQP1—Metabolism—SLC2A1—ovarian cancer	0.000355	0.00236	CbGpPWpGaD
Acetazolamide—Nausea—Epirubicin—ovarian cancer	0.000355	0.000658	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—CCNE1—ovarian cancer	0.000353	0.00235	CbGpPWpGaD
Acetazolamide—Vomiting—Doxorubicin—ovarian cancer	0.000352	0.000651	CcSEcCtD
Acetazolamide—CA5B—Metabolism—PPP1CC—ovarian cancer	0.000348	0.00231	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPP1CC—ovarian cancer	0.000348	0.00231	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—BRIP1—ovarian cancer	0.000348	0.00231	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—BRIP1—ovarian cancer	0.000348	0.00231	CbGpPWpGaD
Acetazolamide—Headache—Doxorubicin—ovarian cancer	0.000346	0.000642	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—SOD2—ovarian cancer	0.000344	0.00229	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CYP1B1—ovarian cancer	0.000341	0.00226	CbGpPWpGaD
Acetazolamide—Nausea—Doxorubicin—ovarian cancer	0.000328	0.000609	CcSEcCtD
Acetazolamide—CA3—Metabolism—FASN—ovarian cancer	0.000324	0.00215	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—BRIP1—ovarian cancer	0.000322	0.00214	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPP1CC—ovarian cancer	0.000322	0.00214	CbGpPWpGaD
Acetazolamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000322	0.00214	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—SLC5A5—ovarian cancer	0.000319	0.00212	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—HRAS—ovarian cancer	0.000313	0.00208	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—SLC2A1—ovarian cancer	0.000308	0.00204	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000306	0.00203	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PPP2R1A—ovarian cancer	0.000302	0.00201	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP1B1—ovarian cancer	0.000295	0.00196	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	0.000295	0.00196	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYTB—ovarian cancer	0.000294	0.00195	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000292	0.00194	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000283	0.00188	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYTB—ovarian cancer	0.000282	0.00187	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	0.000281	0.00187	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—ABCB1—ovarian cancer	0.00028	0.00186	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—TYMS—ovarian cancer	0.000275	0.00183	CbGpPWpGaD
Acetazolamide—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	0.000272	0.0018	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000271	0.0018	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYTB—ovarian cancer	0.00027	0.00179	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PPP2R1A—ovarian cancer	0.000262	0.00174	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPP1CC—ovarian cancer	0.000257	0.00171	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—BRIP1—ovarian cancer	0.000257	0.00171	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—YAP1—ovarian cancer	0.000256	0.0017	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—YAP1—ovarian cancer	0.00025	0.00166	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—YAP1—ovarian cancer	0.00025	0.00166	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPP1CC—ovarian cancer	0.000246	0.00163	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—BRIP1—ovarian cancer	0.000246	0.00163	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ABCB1—ovarian cancer	0.000243	0.00161	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—TYMS—ovarian cancer	0.000239	0.00159	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYTB—ovarian cancer	0.000237	0.00158	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000236	0.00157	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPP1CC—ovarian cancer	0.000236	0.00157	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—BRIP1—ovarian cancer	0.000236	0.00157	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—YAP1—ovarian cancer	0.000233	0.00155	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—YAP1—ovarian cancer	0.000233	0.00155	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000233	0.00155	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CAV1—ovarian cancer	0.000222	0.00147	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—YAP1—ovarian cancer	0.000216	0.00143	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000214	0.00142	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—FASN—ovarian cancer	0.000209	0.00139	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—BRIP1—ovarian cancer	0.000208	0.00138	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPP1CC—ovarian cancer	0.000208	0.00138	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC5A5—ovarian cancer	0.000206	0.00136	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—FASN—ovarian cancer	0.000204	0.00135	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—FASN—ovarian cancer	0.000204	0.00135	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CG—ovarian cancer	0.000202	0.00134	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC5A5—ovarian cancer	0.0002	0.00133	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC5A5—ovarian cancer	0.0002	0.00133	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC2A1—ovarian cancer	0.000198	0.00132	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MTOR—ovarian cancer	0.000195	0.0013	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC2A1—ovarian cancer	0.000193	0.00128	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC2A1—ovarian cancer	0.000193	0.00128	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CAV1—ovarian cancer	0.000192	0.00128	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000192	0.00127	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1B1—ovarian cancer	0.00019	0.00126	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—FASN—ovarian cancer	0.00019	0.00126	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—FASN—ovarian cancer	0.00019	0.00126	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CXCL8—ovarian cancer	0.000188	0.00124	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC5A5—ovarian cancer	0.000187	0.00124	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC5A5—ovarian cancer	0.000187	0.00124	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1B1—ovarian cancer	0.000185	0.00123	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1B1—ovarian cancer	0.000185	0.00123	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1B—ovarian cancer	0.000183	0.00122	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC2A1—ovarian cancer	0.000181	0.0012	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC2A1—ovarian cancer	0.000181	0.0012	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CD—ovarian cancer	0.000178	0.00118	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—FASN—ovarian cancer	0.000176	0.00117	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CG—ovarian cancer	0.000175	0.00116	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC5A5—ovarian cancer	0.000173	0.00115	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1B1—ovarian cancer	0.000173	0.00115	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1B1—ovarian cancer	0.000173	0.00115	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—YAP1—ovarian cancer	0.000172	0.00114	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPP2R1A—ovarian cancer	0.000169	0.00112	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC2A1—ovarian cancer	0.000167	0.00111	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—YAP1—ovarian cancer	0.000165	0.0011	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPP2R1A—ovarian cancer	0.000164	0.00109	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPP2R1A—ovarian cancer	0.000164	0.00109	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1B1—ovarian cancer	0.00016	0.00106	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—YAP1—ovarian cancer	0.000158	0.00105	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ABCB1—ovarian cancer	0.000157	0.00104	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CB—ovarian cancer	0.000155	0.00103	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CD—ovarian cancer	0.000154	0.00102	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TYMS—ovarian cancer	0.000154	0.00102	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPP2R1A—ovarian cancer	0.000154	0.00102	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPP2R1A—ovarian cancer	0.000154	0.00102	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ABCB1—ovarian cancer	0.000153	0.00101	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ABCB1—ovarian cancer	0.000153	0.00101	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—ovarian cancer	0.000152	0.00101	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—STAT3—ovarian cancer	0.000151	0.001	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TYMS—ovarian cancer	0.00015	0.000996	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TYMS—ovarian cancer	0.00015	0.000996	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MAPK3—ovarian cancer	0.000144	0.000956	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000143	0.000949	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ABCB1—ovarian cancer	0.000143	0.000946	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ABCB1—ovarian cancer	0.000143	0.000946	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPP2R1A—ovarian cancer	0.000142	0.000944	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—FASN—ovarian cancer	0.00014	0.000932	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TYMS—ovarian cancer	0.00014	0.00093	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TYMS—ovarian cancer	0.00014	0.00093	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—YAP1—ovarian cancer	0.000139	0.000924	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC5A5—ovarian cancer	0.000138	0.000917	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000138	0.000917	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MAPK1—ovarian cancer	0.000137	0.00091	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—FASN—ovarian cancer	0.000135	0.000894	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CB—ovarian cancer	0.000134	0.000892	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTEN—ovarian cancer	0.000134	0.000889	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC2A1—ovarian cancer	0.000133	0.000886	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC5A5—ovarian cancer	0.000132	0.000879	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ABCB1—ovarian cancer	0.000132	0.000877	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TYMS—ovarian cancer	0.00013	0.000861	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—FASN—ovarian cancer	0.000129	0.000857	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1B1—ovarian cancer	0.000128	0.000849	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC2A1—ovarian cancer	0.000128	0.000849	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC5A5—ovarian cancer	0.000127	0.000843	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CAV1—ovarian cancer	0.000124	0.000823	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1B1—ovarian cancer	0.000123	0.000814	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC2A1—ovarian cancer	0.000123	0.000814	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CAV1—ovarian cancer	0.000121	0.000802	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CAV1—ovarian cancer	0.000121	0.000802	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1B1—ovarian cancer	0.000118	0.00078	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTEN—ovarian cancer	0.000116	0.000771	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—ovarian cancer	0.000115	0.000764	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—FASN—ovarian cancer	0.000113	0.000753	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPP2R1A—ovarian cancer	0.000113	0.000753	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CG—ovarian cancer	0.000113	0.00075	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CAV1—ovarian cancer	0.000113	0.000749	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CAV1—ovarian cancer	0.000113	0.000749	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC5A5—ovarian cancer	0.000112	0.000741	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CG—ovarian cancer	0.00011	0.000731	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CG—ovarian cancer	0.00011	0.000731	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000109	0.000724	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPP2R1A—ovarian cancer	0.000109	0.000722	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A1—ovarian cancer	0.000108	0.000716	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—IL6—ovarian cancer	0.000105	0.000699	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCB1—ovarian cancer	0.000105	0.000699	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CAV1—ovarian cancer	0.000105	0.000694	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPP2R1A—ovarian cancer	0.000104	0.000692	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TYMS—ovarian cancer	0.000103	0.000687	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1B1—ovarian cancer	0.000103	0.000686	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CG—ovarian cancer	0.000103	0.000682	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CG—ovarian cancer	0.000103	0.000682	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000102	0.000675	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCB1—ovarian cancer	0.000101	0.00067	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.0001	0.000666	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CD—ovarian cancer	9.93e-05	0.000659	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TYMS—ovarian cancer	9.92e-05	0.000658	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCB1—ovarian cancer	9.68e-05	0.000643	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CD—ovarian cancer	9.68e-05	0.000642	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CD—ovarian cancer	9.68e-05	0.000642	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CG—ovarian cancer	9.52e-05	0.000632	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMS—ovarian cancer	9.51e-05	0.000631	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—ovarian cancer	9.44e-05	0.000627	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPP2R1A—ovarian cancer	9.17e-05	0.000609	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CD—ovarian cancer	9.03e-05	0.0006	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CD—ovarian cancer	9.03e-05	0.0006	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CB—ovarian cancer	8.66e-05	0.000575	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCB1—ovarian cancer	8.51e-05	0.000565	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CB—ovarian cancer	8.44e-05	0.00056	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CB—ovarian cancer	8.44e-05	0.00056	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CD—ovarian cancer	8.37e-05	0.000556	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMS—ovarian cancer	8.36e-05	0.000555	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CAV1—ovarian cancer	8.34e-05	0.000553	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—ovarian cancer	8.19e-05	0.000544	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CAV1—ovarian cancer	7.99e-05	0.000531	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CB—ovarian cancer	7.88e-05	0.000523	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CB—ovarian cancer	7.88e-05	0.000523	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—ovarian cancer	7.72e-05	0.000512	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CAV1—ovarian cancer	7.66e-05	0.000509	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CG—ovarian cancer	7.59e-05	0.000504	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTEN—ovarian cancer	7.48e-05	0.000497	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CB—ovarian cancer	7.3e-05	0.000484	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTEN—ovarian cancer	7.29e-05	0.000484	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTEN—ovarian cancer	7.29e-05	0.000484	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CG—ovarian cancer	7.28e-05	0.000483	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CG—ovarian cancer	6.98e-05	0.000463	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTEN—ovarian cancer	6.8e-05	0.000452	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTEN—ovarian cancer	6.8e-05	0.000452	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CAV1—ovarian cancer	6.74e-05	0.000447	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—ovarian cancer	6.69e-05	0.000444	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CD—ovarian cancer	6.67e-05	0.000443	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CD—ovarian cancer	6.4e-05	0.000425	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTEN—ovarian cancer	6.3e-05	0.000419	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NME2—ovarian cancer	6.2e-05	0.000412	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CG—ovarian cancer	6.14e-05	0.000407	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CD—ovarian cancer	6.14e-05	0.000407	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CB—ovarian cancer	5.82e-05	0.000386	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CB—ovarian cancer	5.58e-05	0.00037	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CD—ovarian cancer	5.39e-05	0.000358	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CB—ovarian cancer	5.35e-05	0.000355	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—ovarian cancer	5.28e-05	0.00035	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—ovarian cancer	5.14e-05	0.000341	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—ovarian cancer	5.14e-05	0.000341	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTEN—ovarian cancer	5.03e-05	0.000334	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTEN—ovarian cancer	4.82e-05	0.00032	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—ovarian cancer	4.8e-05	0.000319	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—ovarian cancer	4.8e-05	0.000319	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CB—ovarian cancer	4.7e-05	0.000312	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTEN—ovarian cancer	4.62e-05	0.000307	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—ovarian cancer	4.45e-05	0.000295	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—ovarian cancer	4.31e-05	0.000286	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—ovarian cancer	4.2e-05	0.000279	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—ovarian cancer	4.2e-05	0.000279	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTEN—ovarian cancer	4.06e-05	0.00027	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYTB—ovarian cancer	4e-05	0.000265	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—ovarian cancer	3.92e-05	0.00026	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—ovarian cancer	3.92e-05	0.00026	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—ovarian cancer	3.63e-05	0.000241	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—ovarian cancer	3.55e-05	0.000235	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BRIP1—ovarian cancer	3.49e-05	0.000232	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPP1CC—ovarian cancer	3.49e-05	0.000232	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—ovarian cancer	3.4e-05	0.000226	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—ovarian cancer	3.26e-05	0.000216	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—ovarian cancer	2.9e-05	0.000192	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—ovarian cancer	2.87e-05	0.00019	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—ovarian cancer	2.78e-05	0.000184	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—ovarian cancer	2.66e-05	0.000177	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—YAP1—ovarian cancer	2.34e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—ovarian cancer	2.34e-05	0.000155	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—FASN—ovarian cancer	1.91e-05	0.000127	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.88e-05	0.000125	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.81e-05	0.00012	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.74e-05	0.000116	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	1.54e-05	0.000102	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCB1—ovarian cancer	1.43e-05	9.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMS—ovarian cancer	1.41e-05	9.34e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CAV1—ovarian cancer	1.13e-05	7.53e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.03e-05	6.86e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CD—ovarian cancer	9.08e-06	6.03e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CB—ovarian cancer	7.91e-06	5.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTEN—ovarian cancer	6.84e-06	4.54e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—ovarian cancer	4.82e-06	3.2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—ovarian cancer	3.94e-06	2.62e-05	CbGpPWpGaD
